Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Porphyromonas gingivalis experimentally induces periodontis and an anti-CCP2-associated arthritis in the rat.

Courbon G, Rinaudo-Gaujous M, Blasco-Baque V, Auger I, Caire R, Mijola L, Vico L, Paul S, Marotte H.

Ann Rheum Dis. 2019 Jan 30. pii: annrheumdis-2018-213697. doi: 10.1136/annrheumdis-2018-213697. [Epub ahead of print]

PMID:
30700425
2.

Oral health and microbiota status in professional rugby players: A case-control study.

Minty M, Canceill T, Lê S, Dubois P, Amestoy O, Loubieres P, Christensen JE, Champion C, Azalbert V, Grasset E, Hardy S, Loubes JM, Mallet JP, Tercé F, Vergnes JN, Burcelin R, Serino M, Diemer F, Blasco-Baque V.

J Dent. 2018 Dec;79:53-60. doi: 10.1016/j.jdent.2018.10.001. Epub 2018 Oct 5.

PMID:
30292825
3.

The effects of periodontal treatment on diabetic patients: The DIAPERIO randomized controlled trial.

Vergnes JN, Canceill T, Vinel A, Laurencin-Dalicieux S, Maupas-Schwalm F, Blasco-Baqué V, Hanaire H, Arrivé E, Rigalleau V, Nabet C, Sixou M, Gourdy P, Monsarrat P; DIAPERIO Group.

J Clin Periodontol. 2018 Oct;45(10):1150-1163. doi: 10.1111/jcpe.13003. Epub 2018 Sep 14.

PMID:
30136741
4.

Publisher Correction: Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women.

Hoyles L, Fernández-Real JM, Federici M, Serino M, Abbott J, Charpentier J, Heymes C, Luque JL, Anthony E, Barton RH, Chilloux J, Myridakis A, Martinez-Gili L, Moreno-Navarrete JM, Benhamed F, Azalbert V, Blasco-Baque V, Puig J, Xifra G, Ricart W, Tomlinson C, Woodbridge M, Cardellini M, Davato F, Cardolini I, Porzio O, Gentileschi P, Lopez F, Foufelle F, Butcher SA, Holmes E, Nicholson JK, Postic C, Burcelin R, Dumas ME.

Nat Med. 2018 Oct;24(10):1628. doi: 10.1038/s41591-018-0169-5.

PMID:
30093731
5.

Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women.

Hoyles L, Fernández-Real JM, Federici M, Serino M, Abbott J, Charpentier J, Heymes C, Luque JL, Anthony E, Barton RH, Chilloux J, Myridakis A, Martinez-Gili L, Moreno-Navarrete JM, Benhamed F, Azalbert V, Blasco-Baque V, Puig J, Xifra G, Ricart W, Tomlinson C, Woodbridge M, Cardellini M, Davato F, Cardolini I, Porzio O, Gentileschi P, Lopez F, Foufelle F, Butcher SA, Holmes E, Nicholson JK, Postic C, Burcelin R, Dumas ME.

Nat Med. 2018 Jul;24(7):1070-1080. doi: 10.1038/s41591-018-0061-3. Epub 2018 Jun 25. Erratum in: Nat Med. 2018 Aug 9;:.

6.

Author Correction: Obese Subjects With Specific Gustatory Papillae Microbiota and Salivary Cues Display an Impairment to Sense Lipids.

Besnard P, Christensen JE, Brignot H, Bernard A, Passilly-Degrace P, Nicklaus S, Pais de Barros JP, Collet X, Lelouvier B, Servant F, Blasco-Baque V, Verges B, Lagrost L, Feron G, Burcelin R.

Sci Rep. 2018 Jun 22;8(1):9773. doi: 10.1038/s41598-018-27701-w.

7.

Obese Subjects With Specific Gustatory Papillae Microbiota and Salivary Cues Display an Impairment to Sense Lipids.

Besnard P, Christensen JE, Brignot H, Bernard A, Passilly-Degrace P, Nicklaus S, Pais de Barros JP, Collet X, Lelouvier B, Servant F, Blasco-Baque V, Verges B, Lagrost L, Feron G, Burcelin R.

Sci Rep. 2018 Apr 30;8(1):6742. doi: 10.1038/s41598-018-24619-1. Erratum in: Sci Rep. 2018 Jun 22;8(1):9773.

8.

Gut Microbiota Interacts with Markers of Adipose Tissue Browning, Insulin Action and Plasma Acetate in Morbid Obesity.

Moreno-Navarrete JM, Serino M, Blasco-Baque V, Azalbert V, Barton RH, Cardellini M, Latorre J, Ortega F, Sabater-Masdeu M, Burcelin R, Dumas ME, Ricart W, Federici M, Fernández-Real JM.

Mol Nutr Food Res. 2018 Feb;62(3). doi: 10.1002/mnfr.201700721. Epub 2017 Dec 29.

9.

Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism.

Nicolas S, Blasco-Baque V, Fournel A, Gilleron J, Klopp P, Waget A, Ceppo F, Marlin A, Padmanabhan R, Iacovoni JS, Tercé F, Cani PD, Tanti JF, Burcelin R, Knauf C, Cormont M, Serino M.

Mol Syst Biol. 2017 Mar 16;13(3):921. doi: 10.15252/msb.20167356.

10.

Periodontal Tissue Regeneration Using Syngeneic Adipose-Derived Stromal Cells in a Mouse Model.

Lemaitre M, Monsarrat P, Blasco-Baque V, Loubières P, Burcelin R, Casteilla L, Planat-Bénard V, Kémoun P.

Stem Cells Transl Med. 2017 Feb;6(2):656-665. doi: 10.5966/sctm.2016-0028. Epub 2016 Sep 16.

11.

Associations between hepatic miRNA expression, liver triacylglycerols and gut microbiota during metabolic adaptation to high-fat diet in mice.

Blasco-Baque V, Coupé B, Fabre A, Handgraaf S, Gourdy P, Arnal JF, Courtney M, Schuster-Klein C, Guardiola B, Tercé F, Burcelin R, Serino M.

Diabetologia. 2017 Apr;60(4):690-700. doi: 10.1007/s00125-017-4209-3. Epub 2017 Jan 19.

PMID:
28105518
12.

[Microbiotes and metabolic diseases: the bases for therapeutic strategies].

Burcelin R, Nicolas S, Blasco-Baque V.

Med Sci (Paris). 2016 Nov;32(11):952-960. doi: 10.1051/medsci/20163211010. Epub 2016 Dec 23. Review. French.

13.

Gestational diabetes is associated with changes in placental microbiota and microbiome.

Bassols J, Serino M, Carreras-Badosa G, Burcelin R, Blasco-Baque V, Lopez-Bermejo A, Fernandez-Real JM.

Pediatr Res. 2016 Dec;80(6):777-784. doi: 10.1038/pr.2016.155. Epub 2016 Aug 4.

PMID:
27490741
14.

Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia.

Pomié C, Blasco-Baque V, Klopp P, Nicolas S, Waget A, Loubières P, Azalbert V, Puel A, Lopez F, Dray C, Valet P, Lelouvier B, Servant F, Courtney M, Amar J, Burcelin R, Garidou L.

Mol Metab. 2016 Mar 28;5(6):392-403. doi: 10.1016/j.molmet.2016.03.004. eCollection 2016 Jun.

15.

Young microbes for adult obesity.

Serino M, Nicolas S, Trabelsi MS, Burcelin R, Blasco-Baque V.

Pediatr Obes. 2017 Aug;12(4):e28-e32. doi: 10.1111/ijpo.12146. Epub 2016 May 2. Review.

PMID:
27135640
16.

Periodontal dysbiosis linked to periodontitis is associated with cardiometabolic adaptation to high-fat diet in mice.

Branchereau M, Reichardt F, Loubieres P, Marck P, Waget A, Azalbert V, Colom A, Padmanabhan R, Iacovoni JS, Giry A, Tercé F, Heymes C, Burcelin R, Serino M, Blasco-Baque V.

Am J Physiol Gastrointest Liver Physiol. 2016 Jun 1;310(11):G1091-101. doi: 10.1152/ajpgi.00424.2015. Epub 2016 Mar 31.

17.

Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response.

Blasco-Baque V, Garidou L, Pomié C, Escoula Q, Loubieres P, Le Gall-David S, Lemaitre M, Nicolas S, Klopp P, Waget A, Azalbert V, Colom A, Bonnaure-Mallet M, Kemoun P, Serino M, Burcelin R.

Gut. 2017 May;66(5):872-885. doi: 10.1136/gutjnl-2015-309897. Epub 2016 Feb 2.

18.

Hepatitis E, the neglected one.

Blasco-Perrin H, Abravanel F, Blasco-Baque V, Péron JM.

Liver Int. 2016 Jan;36 Suppl 1:130-4. doi: 10.1111/liv.13014. Review.

PMID:
26725910
19.

Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences.

Serino M, Blasco-Baque V, Nicolas S, Burcelin R.

Curr Cardiol Rep. 2014 Nov;16(11):540. doi: 10.1007/s11886-014-0540-1. Review.

20.

Managing the manager: gut microbes, stem cells and metabolism.

Serino M, Blasco-Baque V, Nicolas S, Burcelin R.

Diabetes Metab. 2014 Jun;40(3):186-90. doi: 10.1016/j.diabet.2013.12.004. Epub 2014 Jan 23. Review.

PMID:
24462190
21.

[Intestinal microbiota and novel therapeutic perspectives for the treatment of metabolic diseases].

Burcelin R, Chabo C, Blasco-Baque V, Sérino M, Amar J.

Med Sci (Paris). 2013 Aug-Sep;29(8-9):800-6. doi: 10.1051/medsci/2013298021. Epub 2013 Sep 5. Review. French.

22.

[Metabolic therapy at the edge between human hosts and gut microbes].

Blasco-Baque V, Serino M, Burcelin R.

Ann Pharm Fr. 2013 Jan;71(1):34-41. doi: 10.1016/j.pharma.2012.08.003. Epub 2012 Oct 9. Review. French.

PMID:
23348854
23.

High-fat diet induces periodontitis in mice through lipopolysaccharides (LPS) receptor signaling: protective action of estrogens.

Blasco-Baque V, Serino M, Vergnes JN, Riant E, Loubieres P, Arnal JF, Gourdy P, Sixou M, Burcelin R, Kemoun P.

PLoS One. 2012;7(11):e48220. doi: 10.1371/journal.pone.0048220. Epub 2012 Nov 2. Erratum in: PLoS One. 2013;8(5). doi:10.1371/annotation/83ddaae2-ce5d-4683-bbff-f87945a2fa2c.

24.

Microbes on-air: gut and tissue microbiota as targets in type 2 diabetes.

Serino M, Blasco-Baque V, Burcelin R.

J Clin Gastroenterol. 2012 Oct;46 Suppl:S27-8. doi: 10.1097/MCG.0b013e318264e844.

PMID:
22955352
25.

[Impact of periodontal disease on arterial pressure in diabetic mice].

Blasco-Baque V, Kémoun P, Loubieres P, Roumieux M, Heymes C, Serino M, Sixou M, Burcelin R.

Ann Cardiol Angeiol (Paris). 2012 Jun;61(3):173-7. doi: 10.1016/j.ancard.2012.04.012. Epub 2012 May 7. French.

PMID:
22621847
26.

Gut microbiota and diabetes: from pathogenesis to therapeutic perspective.

Burcelin R, Serino M, Chabo C, Blasco-Baque V, Amar J.

Acta Diabetol. 2011 Dec;48(4):257-273. doi: 10.1007/s00592-011-0333-6. Epub 2011 Oct 2. Review.

27.

Impact of type 2 diabetes on the development of periodontal disease in the mouse.

Blasco-Baque V, Kemoun P, Loubieres P, Arnal JF, Gourdy P, Serino M, Burcelin R, Sixou M.

Bull Group Int Rech Sci Stomatol Odontol. 2011 Nov 22;50(2):11-2. No abstract available.

PMID:
22750698

Supplemental Content

Loading ...
Support Center